Safety And Efficacy Of Dexmedetomidine Sedation In Intubated Mechanically Ventilated Infants With Respiratory Failure
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
Dexmedetomidine is a highly selective α2-agonist with hypnotic, analgesic, and anxiolytic
properties. Despite off-label administration, dexmedetomidine has found a niche in critically
ill mechanically ventilated neonates and infants because of its minimal effects on
respiratory function at sedative doses, facilitating early extubation and fast-track
postoperative care.